RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:521258

Xq25 microduplication syndrome

low confidenceDisorder

Also known as: Dup(X)(q25) · Xq25 microtriplication

Publications

4,115

Trials

0

Interventional, condition-specific

Researchers

207

Distinct authors in sample

Gene link

STAG2

Limited

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

A rare, X-linked, multiple anomalies/ - syndrome characterized by , mild to moderate , speech disturbance, behavioral problems (such as anxiety, hyperactivity, and aggressiveness) and mild facial dysmorphism (including facial , thin arched eyebrows, ectropion, epicanthus, malar flatness, thick vermillion of the lips and prognathia). Additional variable manifestations include short stature, skeletal and genital anomalies, , and autism spectrum disorders. Brain imaging may reveal cerebellar vermis hypoplasia, thin corpus callosum, and enlarged subarachnoid spaces.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

Xq25 duplication syndrome

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Limited — STAG2

  2. LiteraturePresent

    4,115 matched papers (3,567 in last 10 years) Source

  3. Phenotype characterisedPresent

    41 HPO annotations (e.g. Malar flattening; Facial hypotonia; Mandibular prognathia) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Possibly — only limited evidence so far for STAG2.

GenCC classification: Limited.

Phenotypes (Monarch / HPO)

41

Associated phenotypes · MONDO:0010507

  • Malar flattening
  • Facial hypotonia
  • Mandibular prognathia
  • Autistic behavior
  • Anxiety

Showing 5 of 41 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

4,115

4,115 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

4,115 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

3,567 in the last 10 years · low confidence

Phrase hits: 19 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

207

Distinct author names in 19 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Colleaux L2 papers · 2016

    Sorbonne Paris Cité, Université Paris Descartes, Paris, France.

    Papers in Europe PMC
  2. 02
    Cormier-Daire V2 papers · 2016

    Service de Génétique, Hôpital Necker-Enfants Malades, Paris, France.

    Papers in Europe PMC
  3. 03
    Jacquemont ML2 papers · 2016

    INSERM U781, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France.

    Papers in Europe PMC
  4. 04
    Philippe A2 papers · 2016

    Service de Génétique, Hôpital Necker-Enfants Malades, Paris, France.

    Papers in Europe PMC
  5. 05
    Vekemans M2 papers · 2016

    Service de Cytogénétique, Hôpital Necker-Enfants Malades, Paris, France.

    Papers in Europe PMC
  6. 06
    Wang D2 papers · 2021

    Eugenic and Perinatal Institute, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

    Papers in Europe PMC
  7. 07
    Yang X2 papers · 2021

    Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

    Papers in Europe PMC
  8. 08
    Abhyankar A1 paper · 2023

    Molecular Diagnostics, New York Genome Center, New York, New York, USA.

    Papers in Europe PMC
  9. 09
    Abul-Husn NS1 paper · 2023

    Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

    Papers in Europe PMC
  10. 10
    Agafonova AA1 paper · 2025

    Medical Genetic Center (Genetic Clinic), Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, 634050, Russia.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Xq25 microduplication syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Xq25 microduplication syndrome" OR "Dup(X)(q25)" OR "Xq25 microtriplication" OR "Xq25 duplication syndrome") OR ("STAG2" OR "STAG2 syndrome" OR "STAG2-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Xq25 microduplication syndrome" OR "Dup(X)(q25)" OR "Xq25 microtriplication" OR "Xq25 duplication syndrome"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (4115) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T18:02:05.120Z